Over the last several years, federal concern about genetic testing has been steadily growing. Regulators have watched Medicare Part B spending on molecular and genetic tests spike while a relatively ...
Assessing the understanding and utilization of integrative oncology among patients with a history of cancer. An international expert consensus on improving the quality of care in patients with cancer ...
The bankruptcy of direct-to-consumer genetic testing firm 23andMe—named as “Invention of the Year” in 2008 by Time magazine—is a cautionary tale, says Boston College Law Assistant Professor Shelly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results